The Path to Reemergence

03.11.2022

Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma Manufacturing on lessons learned from COVID, and the path forward to future pandemic preparedness.

Read the full article here.

CITATION

K. Langhauser, "Emergent BioSolutions: The path to reemergence," Pharma Manufacturing, February 10, 2022.

Emergent CDMO

COVID-19 In The News

Thought Leadership
In The News
Webinars
White Papers
Video Library
Case Studies

10.01.2020

Bloomberg: The Way Ahead

Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...

07.05.2021

Lyophilized products are on the rise: Here's what you need to know

There has been a steady increase in demand for lyophilized products in recent years. Due in large part to biologic drug...

04.26.2023

Case Study Corner: LNP Formulation

Your biggest challenges inspire us. That's why Emergent supports innovative drug makers that make the seemingly impossible...